Data Bridge Market Research analyses that the immunoglobulins market was valued at USD 13,096.89 million in 2021 and is expected to reach USD 22,587.15 billion by 2029, registering a CAGR of 7.05% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

 

Immunoglobulins, often known as antibodies, are a type of glycoprotein molecule produced by plasma or white blood cells (WBCs). They are found in the immune system’s serum and cells and work like antibodies by identifying and binding antigens, such as bacteria or viruses, and assisting in their elimination. Their tests aid in the diagnosis of immunodeficiencies, allergies, and autoimmune diseases such as juvenile idiopathic arthritis, lupus, and celiac disease, among others. Immunoglobulins are classified into several classes based on biological characteristics, structure, target specificity, and distribution.

 

Because of the rise in the incidence of autoimmune illnesses, the worldwide immunoglobulins market is expected to grow rapidly. According to the Immune Deficiency Foundation (IDF), primary immunodeficiency affected 83 out of every 100,000 people in North America in 2017, resulting in 350 hereditary disorders. As the world’s geriatric population grows, so does the demand for more effective immunological therapies.

 

 

 

 

 

 

The immunoglobulins market is segmented on the basis of product, applications and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

 

 

 

On the basis of application, the immunoglobulins market is segmented into hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy, immunodeficiency disease, myasthenia gravis, multifocal motor neuropathy, idiopathic thrombocytopenic purpura, inflammatory myopathies, specific antibody deficiency, guillain-barré syndrome, and others.

 

 

On the basis of product, the immunoglobulins market is segmented into IgA, IgG, IgM, IgE, and IgD.

 

 

 

 

 

The rise in chronic inflammatory demyelinating polyneuropathy (CIDP), hypogammaglobulinemia, and other illnesses is projected to drive market expansion. One of the key drivers of market expansion is the rising number of patients with medical illnesses such as multiple myeloma, Waldenstrom macroglobulinemia, and autoimmune disorders.

 

The market is also benefiting from the growing prevalence of sedentary lifestyle. Individuals are increasingly consuming fast food as a result of increased urbanization and stressful lifestyles.

 

Furthermore, the growing geriatric population will act as major factor influencing the growth of immunoglobulins market. Along with this, increasing awareness about early diagnosis and rising level of disposable income are the driving factors accelerating the growth of the immunoglobulins market. Also, increasing expenditure on healthcare infrastructure and increasing preferences for personalized medicines are the major market drivers that will further escalate the growth of immunoglobulins market.

 

 

Moreover, the market’s growth is fueled by an increase in the number of research and development activities which will further provide beneficial opportunities for the immunoglobulins market growth.

 

Moreover, rising investment for the development of advanced technologies and an increase in the number of emerging markets will provide beneficial opportunities for the immunoglobulins market growth during the forecast period.

 

 

On the other hand, the high cost associated with immunoglobulins will obstruct the growth rate of market. The dearth of skilled professionals and rising risk of side effects linked with the use of immunoglobulin will challenge the immunoglobulins market. Additionally, impact of COVID-19 on supply chain and introduction of alternative technology will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

 

 

 

 

 

 

Part 01: Executive Summary

 

Part 02: Scope of the Report

 

Part 03: Global Immunoglobulins Market Landscape

 

Part 04: Global Immunoglobulins Market Sizing

 

Part 05: Global Immunoglobulins Market Segmentation by Product

 

Part 06: Five Forces Analysis

 

Part 07: Customer Landscape

 

Part 08: Geographic Landscape

 

Part 09: Decision Framework

 

Part 10: Drivers and Challenges

 

Part 11: Market Trends

 

Part 12: Vendor Landscape

 

Part 13: Vendor Analysis

 

 

 

 

 

 Global Fetal Alcohol Spectrum Disorder Fasd MarketSize, Share and Opportunities https://www.databridgemarketresearch.com/reports/global fetal alcohol spectrum disorder fasd market

 

 Global High Blood Pressure Treatment MarketSize, Share and Opportunities https://www.databridgemarketresearch.com/reports/global high blood pressure treatment market

 

 Global Immunoglobulins MarketSize, Share and Opportunities https://www.databridgemarketresearch.com/reports/global immunoglobulins market

 

 Global In Line Uv Vis Spectroscopy MarketSize, Share and Opportunities https://www.databridgemarketresearch.com/reports/global in line uv vis spectroscopy market

 

 Global Karyotyping MarketSize, Share and Opportunities https://www.databridgemarketresearch.com/reports/global karyotyping market

 

 Global Medical Vacuum System MarketSize, Share and Opportunities https://www.databridgemarketresearch.com/reports/global medical vacuum system market

 

 Global Mineral Supplements MarketSize, Share and Opportunities https://www.databridgemarketresearch.com/reports/global mineral supplements market

 

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

 

 

 

US: +1 888 387 2818

 

UK: +44 208 089 1725

 

Hong Kong: +852 8192 7475

 

Email: [email protected]